ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01094405
Recruitment Status : Active, not recruiting
First Posted : March 29, 2010
Last Update Posted : January 12, 2018
Sponsor:
Information provided by (Responsible Party):
CCTU, Chinese University of Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018